If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,500.00
Bid: 4,440.00
Ask: 4,500.00
Change: 20.00 (0.45%)
Spread: 60.00 (1.351%)
Open: 4,500.00
High: 4,500.00
Low: 4,500.00
Prev. Close: 4,480.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of holding in BF&M Limited

6 Jun 2023 12:00

RNS Number : 8288B
Camellia PLC
06 June 2023
 

6 June 2023

Camellia Plc

(the "Company" or "Camellia")

 

Sale of holding in BF&M Limited ("BF&M")

 

 

Camellia is pleased to announce it has entered into an agreement for the sale of its entire holding of 3,394,403 shares (approximately 36.9%) in BF&M, one of its associate companies, to Bermuda Life Insurance Company Limited, a subsidiary of Argus Group Holdings Limited for a cash consideration totalling US$100.0 million (approximately £80.4 million), a premium of 34% to the closing price of a BF&M share on 5 June 2023 and a premium of 31% to the book value of Camellia's holding as at 31 December 2022. Any special dividend declared and paid by BF&M (if any) between the signing of the agreement and completion will be deducted from the cash consideration. This sale represents a further step in Camellia's policy of divesting non-core assets.

 

The disposal is conditional on the satisfaction of certain conditions, including regulatory and tax approvals and notifications in a number of jurisdictions, and the satisfaction of customary conditions precedent. Subject to the satisfaction or waiver of these conditions, completion is expected in Autumn 2023.

 

It is possible that taxes and/or fees may become payable in securing the necessary pre-closing approvals and notifications although such amount cannot be determined until the required applications have been submitted. If Camellia's share of such items exceeds agreed thresholds then the Company has the ability to terminate the contract should it so wish. The purchaser has the same termination right in respect of their share of such costs.

 

Whilst completion of the transaction is not expected until Q4 2023 and therefore the exact use of proceeds may vary depending on circumstances between now and completion, the receipt of the funds realised by this sale, together with funds raised from the disposal of other non-core assets, will enable the Company to accelerate its development programme and continue to diversify its agricultural production by crop and geographic location. The Board considers Camellia's shares to be significantly undervalued and, in the event of any surplus funds arising, will also therefore consider the merit of returning these to shareholders by means of a share buy-back. The Company may, in the meantime, undertake a modest buyback exercise in accordance with the authority given at the Annual General Meeting.

 

BF&M Limited is the holding company of the BF&M group of companies ("BF&M Group") which is a Bermuda listed insurance group operating in Bermuda and the Caribbean. The two largest operating companies within the BF&M Group are BF&M Life Insurance Company Limited, a leading provider of life, health and pensions products, and BF&M General Insurance Company Limited, the leading general insurer providing all forms of property, casualty, motor and marine products.

 

Over recent years BF&M's results have been volatile and in 2022 have been materially adversely impacted by the fluctuations in financial markets and this, together with increased underwriting exposure, has led Camellia to view this investment as beyond its risk appetite.

 

In the year ended 31 December 2022 Camellia's share of the results of BF&M was a loss of £3.7 million (2021: profit of £6.4 million). 

 

Camellia's net assets attributable to the BF&M holding as at 31 December 2022 was £61.5 million and the value of the shares using the closing price for BF&M shares on 5 June 2023 was £59.9 million. The sale is expected to generate a gain on disposal which will be calculated at completion of the transaction.

 

Argus Group Holdings Limited is significant Bermuda listed multi-line insurance and financial services organisation offering a full range of insurance, pensions and investment products internationally. 

 

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

H/Advisers Maitland

PR

William Clutterbuck 07785 292617

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSSLFSMEDSELM
Date   Source Headline
28th Sep 20057:02 amRNSOffer for Linton Park Plc
28th Sep 20057:00 amRNSInterim Results
15th Sep 20054:44 pmRNSHolding(s) in Company
15th Sep 20054:34 pmRNSTransfer of Shares
9th Sep 200511:30 amRNSEPT Disclosure
5th Sep 200510:45 amRNSEPT Disclosure
1st Sep 200511:55 amRNSEPT Disclosure
30th Aug 200510:48 amRNSEPT Disclosure
26th Aug 200510:59 amRNSEPT Disclosure
26th Aug 200510:59 amRNSRule 8.3 - Camellia plc
24th Aug 200510:39 amRNSEPT Disclosure
19th Aug 200510:35 amRNSEPT Disclosure
18th Aug 200511:26 amRNSEPT Disclosure
16th Aug 20055:51 pmRNSEPT Disclosure
16th Aug 200510:12 amRNSEPT Disclosure
15th Aug 200510:54 amRNSEPT Disclosure
9th Aug 200510:59 amRNSEPT Disclosure
5th Aug 200510:56 amRNSEPT Disclosure
4th Aug 200510:13 amRNSEPT Disclosure
3rd Aug 200511:51 amRNSRule 8.3- Camellia plc
3rd Aug 200510:17 amRNSEPT Disclosure
1st Aug 200510:21 amRNSEPT Disclosure
27th Jul 200510:30 amRNSEPT Disclosure
26th Jul 200511:05 amRNSEPT Disclosure
20th Jul 200510:35 amRNSEPT Disclosure
18th Jul 200510:29 amRNSEPT Disclosure
7th Jul 200511:16 amRNSEPT Disclosure
17th Jun 200510:40 amRNSEPT Disclosure
13th Jun 20056:00 pmRNSEPT Disclosure
7th Jun 20051:00 pmRNSAGM Statement
7th Jun 200510:50 amRNSStatement re possible offer
7th Jun 200510:50 amRNSStatement re possible offer
9th May 20052:00 pmRNSReport and accounts 2004
28th Apr 20053:04 pmRNSFinal Results
31st Mar 20054:01 pmRNSEACP
17th Feb 20052:01 pmRNSAcquisition
3rd Feb 200512:17 pmRNSEACP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.